Image (0ed6c856 4d95 4aeb B925 15346555a2ab 565 2)
Topiramate Tablet, Film Coated
Product Images NDC 68071-3660
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Topiramate (NDC 68071-3660). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Nucare Pharmaceuticals,inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Pdp (68071 3660 3)
The text provides information about a medication called Topiramate 25mg, including its appearance, packaging details, expiration date, manufacturer, and specific markings on the tablets. It also includes a reminder to consult a doctor for medical advice and how to report side effects to the FDA. The text contains a warning to keep the medication out of reach of children and instructions on proper storage temperature.*
Image (9df497de Be9f 4244 A769 A72a0e64dc42 01)
Image (9df497de Be9f 4244 A769 A72a0e64dc42 02)
This is a description of cumulative rates for time to the first seizure based on the treatment with two doses of topiramate. The chart shows the comparison between Topiramate 50mg/day and Topiramate 400mg/day in a study involving 234 and 236 participants respectively. The p-value for the comparison is 0.00002, indicating a significant difference between the two groups. The x-axis represents time in days, while the y-axis shows the cumulative rates.*
Image (9df497de Be9f 4244 A769 A72a0e64dc42 03)
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
